Clinical Outcomes of Ruxolitinib in the Salvage Treatment of Chronic Graft-Versus-Host Disease

被引：0
|
作者：
Ji, Yanping [1 ]
Tang, Baolin [2 ]
Zhu, Xiaoyu [2 ]
Liu, Huilan [2 ]
Song, Kaidi [2 ]
Wan, Xiang [2 ]
Yao, Wen [2 ]
Sun, Guangyu [2 ]
Wang, Jian [3 ]
Sun, Zimin [2 ]
机构：
[1] Anhui Med Univ, Anhui Prov Hosp, Hefei, Peoples R China
[2] Univ Sci & Technol China, Affiliated Hosp 1, Div Life Sci & Med, Hefei, Peoples R China
[3] Univ Sci & Technol China, Anhui Prov Hosp, Hefei, Peoples R China
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-130138
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5677
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Efficacy and tolerance of ruxolitinib in refractory sclerodermatous chronic graft-versus-host disease
    Hurabielle, C.
    de Fontbrune, F. Sicre
    Moins-Teisserenc, H.
    Robin, M.
    Jachiet, M.
    Coman, T.
    Dhedin, N.
    Cassius, C.
    Chasset, F.
    de Masson, A.
    Michonneau, D.
    Bagot, M.
    Bergeron, A.
    Socie, G.
    de Latour, R. Peffault
    Bouaziz, J-D
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (05) : E206 - E208
  • [32] Real World Use of Ruxolitinib in Pulmonary Chronic Graft-versus-Host Disease
    Zhang, Z.
    Hefazi, M.
    Peters, S. G.
    Kennedy, C. C.
    Yadav, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [33] Ruxolitinib: a game changer in paediatric chronic graft-versus-host disease management?
    Sisinni, Luisa
    LANCET HAEMATOLOGY, 2024, 11 (08): : e553 - e555
  • [34] Rituximab as salvage therapy for refractory chronic graft-versus-host disease
    Mohty, M.
    Marchetti, N.
    El-Cheikh, J.
    Faucher, C.
    Fuerst, S.
    Blaise, D.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S231 - S231
  • [35] Rapamycine (Sirolimus) as salvage therapy for chronic graft-versus-host disease
    Jurado, M
    Vallejo, C
    Pérez-Simón, J
    Brunet, S
    Balsalobre, P
    Pérez-Oteyza, J
    Espigado, I
    Romero, A
    Caballero, D
    Díez, J
    Vázquez, L
    BONE MARROW TRANSPLANTATION, 2005, 35 : S139 - S139
  • [36] Experience with Ruxolitinib (Jakafi®) As a Salvage Therapy for Graft-Versus-Host Disease in Children and Young Adults
    Mavers, Melissa
    Klinger, Edna
    Shyr, David C.
    Shah, Ami J.
    Bertaina, Alice
    Soni, Sandeep
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S179 - S179
  • [37] Treatment of chronic graft-versus-host disease with rituximab
    Bacigalupo, A
    Lamparelli, T
    Van Lint, M
    Frassoni, F
    Ibatici, A
    Bregante, S
    Gualandi, F
    Raiola, A
    BONE MARROW TRANSPLANTATION, 2005, 35 : S42 - S43
  • [38] Diagnosis and treatment of chronic graft-versus-host disease
    Gilman, AL
    Serody, J
    SEMINARS IN HEMATOLOGY, 2006, 43 (01) : 70 - 80
  • [39] Treatment of chronic graft-versus-host disease with clofazimine
    Lee, BSJ
    Wegner, SA
    McGarigle, CJ
    Bierer, BE
    Antin, JH
    BLOOD, 1997, 89 (07) : 2298 - 2302
  • [40] Rituximab in treatment of chronic graft-versus-host disease
    Hilgendorf, I.
    Kuchlbauer, S.
    Wolff, D.
    Ammer, J.
    Holler, B.
    Hahn, J.
    Edinger, M.
    Freund, M.
    Andreesen, R.
    Holler, E.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S398 - S398
12345